Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

$24.99

Common-Size Income Statement
Quarterly Data

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Medtronic PLC, common-size consolidated income statement (quarterly data)

Microsoft Excel
3 months ended: Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021 Apr 30, 2021 Jan 29, 2021 Oct 30, 2020 Jul 31, 2020 Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018
Net sales
Cost of products sold, excluding amortization of intangible assets
Gross profit
Research and development expense
Selling, general, and administrative expense
Amortization of intangible assets
Restructuring charges, net
Certain litigation charges, net
Other operating income (expense), net
Operating profit
Other non-operating income, net
Interest expense, net
Income before income taxes
Income tax (provision) benefit
Net income
Net income attributable to noncontrolling interests
Net income attributable to Medtronic

Based on: 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31), 10-K (reporting date: 2020-04-24), 10-Q (reporting date: 2020-01-24), 10-Q (reporting date: 2019-10-25), 10-Q (reporting date: 2019-07-26), 10-K (reporting date: 2019-04-26), 10-Q (reporting date: 2019-01-25), 10-Q (reporting date: 2018-10-26), 10-Q (reporting date: 2018-07-27).

The analysis of the quarterly financial data reveals several notable trends in various financial metrics expressed as a percentage of net sales over the examined periods.

Gross Profit
Gross profit margin started near 70%, exhibiting a decreasing trend with notable troughs around April to July 2020, when it dropped to approximately 61.5%. After this low point, it showed a partial recovery and fluctuated mostly between mid-60% levels in subsequent quarters, indicating variable cost pressures.
Cost of Products Sold
The cost of products sold margin generally increased during the same period that gross profit declined, surging particularly in early 2020, reaching a peak near 38.5%. Post-2020, it slightly receded but remained elevated relative to earlier periods, maintaining a range mostly between 33% to 35%, signifying rising production or procurement costs relative to net sales.
Research and Development Expense
R&D expenses as a percentage of net sales were relatively stable around 7.3% to 7.9% in the early periods but showed an increase during 2020 reaching peaks near 9.5%, possibly reflecting increased investment or strategic prioritization during uncertain times. This percentage later moderated back closer to around 8% to 8.5%, demonstrating some normalization in R&D spending intensity.
Selling, General, and Administrative Expenses (SG&A)
SG&A expenses fluctuated notably, starting around 32% to 35%, spiking significantly during the early 2020 period where it reached near 39.3%, indicating higher operating expenses possibly driven by pandemic-related factors or operational adjustments. Afterward, these expenses generally decreased, maintaining a range slightly below 34%, suggesting better cost management or operational efficiencies.
Amortization of Intangible Assets
Amortization expenses remained relatively consistent across the periods, oscillating between approximately 4.9% and 6.0%, without significant trend changes, indicating stable intangible asset charges.
Restructuring Charges
Restructuring charges were mostly below 1%, with a few spikes including a notable increase to -3.43% in one quarter during early 2023, reflecting episodic cost associated with restructuring activities. Generally, these charges were sporadic but made a noticeable impact when incurred.
Certain Litigation Charges
Litigation charges varied, often negative but occasionally positive, showing some volatility with no consistent trend. The data reflects intermittent legal-related expenses impacting profitability with occasional relief periods.
Other Operating Income/Expense
This item presented significant volatility, ranging from negative values close to -9.5% to positive spikes above 1.5%. The sharp negative movements suggest episodic operating costs or income losses, while positive values indicate occasional income boosts outside core operations.
Operating Profit
Operating profit margin demonstrated a wide range from a low around 5.3% in early 2020 to highs exceeding 23% in earlier years. Despite disruptions leading to severe dips in 2020, the margin showed substantial recovery and stabilization in subsequent quarters generally fluctuating between 15% and 20%, indicating resilient operational performance post-crisis.
Other Non-operating Income
Other non-operating income remained positive and fairly steady, usually between 0.7% and 2%, providing a stable supplementary income component.
Interest Expense
Interest expense showed fluctuations, notably worsening in some quarters (e.g., reaching -8.8% in early 2019), but mostly ranged between -1.5% and -3.5%, suggesting variable debt servicing costs, possibly influenced by changing debt levels or interest rates.
Income Before Income Taxes
This metric closely mirrored operating profit trends, with peaks above 20% in some quarters and troughs as low as approximately 3.4% in early 2020. The pattern indicates that income before tax was heavily influenced by operational performance but also affected by non-operating items and interest expenses.
Income Tax Provision
Income tax rates varied widely, with some periods showing tax benefits (positive values) and others reflecting substantial tax expenses. Significantly negative tax impacts occurred notably in late 2022, likely linked to underlying operational or accounting factors.
Net Income
Net income margins fluctuated from a high above 24% in early 2020 to lows near 5.7% in late 2022, mirroring the volatility observed in operating profits and tax expenses. Noteworthy is the sharp decline in profitability during 2020 followed by a rebound and subsequent volatility, indicating sensitivity to extraordinary events or operational disruptions.
Net Income Attributable to Noncontrolling Interests
This component was relatively minor, fluctuating marginally around zero with small positive or negative effects, indicating limited impact on consolidated net income from noncontrolling interests.
Net Income Attributable to the Company
Net income attributable to the company closely aligned with overall net income trends, reflecting the core profitability dynamics after minor adjustments for noncontrolling interests.

Overall, the data portrays a company experiencing significant operational and financial variability, particularly during the early 2020 period consistent with external economic or market disruptions. Post-2020, recovery in operating margins and net income is evident, though underlying cost pressures and episodic charges, such as restructuring and litigation, create fluctuations. Stable R&D and amortization expenses suggest consistent investment and accounting treatments, while fluctuating tax rates contribute to net income variability. The interplay among cost structure, operating income, and non-operating items underlies the main drivers of the periodic profitability changes observed.